Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2011

Hundley AF, Magro C, Bartholomew D. Vaginal agglutination: chronic graft-versus-host disease mimics lichen planus. J Low Genit Tract Dis. 2011;15(1):71-4.

Loukeris K, Salvatore SP, Hoda RS. Pulmonary zygomycoses in an immunosuppressed patient. Diagn Cytopathol. 2011;39(1):37.

Rosai J. Thymomas, committees, and memory lapses. Am J Clin Pathol. 2011;135(4):648; author reply 649.

Feser J, Tyler J. Chromatin structure as a mediator of aging. FEBS Lett. 2011;585(13):2041-8.

Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). 2011;4(7):1021-9.

Flavin R, Zadra G, Loda M. Metabolic alterations and targeted therapies in prostate cancer. J Pathol. 2011;223(2):283-94.

Cushing M, Shaz BH. Blood transfusion in trauma patients: unresolved questions. Minerva Anestesiol. 2011;77(3):349-59.

Magro CM, Poe JC, Lubow M, Susac JO. Susac syndrome: an organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol. 2011;136(6):903-12.

Mosquera J-, Dal Cin P, Mertz KD, Perner S, Davis IJ, Fisher DE, et al. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Diagn Mol Pathol. 2011;20(3):129-37.

Nardella C, Lunardi A, Fedele G, Clohessy JG, Alimonti A, Kozma SC, et al. Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis. Cancer Res. 2011;71(10):3669-75.